Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications.

Evangelista L, Baretta Z, Vinante L, Bezzon E, De Carolis V, Cervino AR, Gregianin M, Ghiotto C, Saladini G, Pomerri F, Muzzio PC.

Q J Nucl Med Mol Imaging. 2012 Aug;56(4):375-84.

PMID:
23013667
2.

A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis L, Arvanitis T, Deeks J, Hyde C.

Health Technol Assess. 2010 Oct;14(50):1-103. doi: 10.3310/hta14500. Review.

3.

18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.

Lin CY, Chen JH, Liang JA, Lin CC, Jeng LB, Kao CH.

Eur J Radiol. 2012 Sep;81(9):2417-22. doi: 10.1016/j.ejrad.2011.08.004. Epub 2011 Sep 6. Review.

PMID:
21899970
4.

Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review.

Sharma P, Singhal A, Kumar A, Bal C, Malhotra A, Kumar R.

Acta Radiol. 2013 Feb 1;54(1):14-21. doi: 10.1258/ar.2012.120536. Review.

PMID:
23377872
5.

A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.

Krug B, Crott R, de Cannière L, D'Hondt L, Vander Borght T.

Colorectal Dis. 2013 Nov;15(11):e627-33. doi: 10.1111/codi.12295. Review.

PMID:
24192263
6.

PET/CT in the imaging of ovarian Cancer.

O'Connor OJ, Prakash P, Cronin CG, McDermott S, Blake MA.

Front Biosci (Elite Ed). 2013 Jan 1;5:141-53. Review.

PMID:
23276977
7.
8.

Current and future perspectives in diagnostic imaging as a guide to targeted/local therapies in breast cancer recurrence.

Evangelista L, Mezzato C, Felloni G, Saladini G.

Q J Nucl Med Mol Imaging. 2013 Dec;57(4):367-80. Review.

PMID:
24322793
9.

Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.

Cocker MS, Mc Ardle B, Spence JD, Lum C, Hammond RR, Ongaro DC, McDonald MA, Dekemp RA, Tardif JC, Beanlands RS.

J Nucl Cardiol. 2012 Dec;19(6):1211-25. doi: 10.1007/s12350-012-9631-9. Review.

10.

Utility of FDG PET/CT in the assessment of myeloid sarcoma.

Lee EY, Anthony MP, Leung AY, Loong F, Khong PL.

AJR Am J Roentgenol. 2012 May;198(5):1175-9. doi: 10.2214/AJR.11.7743. Review.

PMID:
22528910
11.

PET/CT and breast cancer.

Hegarty C, Collins CD.

Cancer Imaging. 2010 Oct 4;10 Spec no A:S59-62. doi: 10.1102/1470-7330.2010.9031. Review.

12.

Structural, pathophysiological and clinical aspects of diagnostic imaging in breast recurrence: the breast after treatment.

Cuccurullo V, Cascini GL, Mansi L.

Q J Nucl Med Mol Imaging. 2013 Dec;57(4):322-31. Review.

13.

Male breast cancer: a different disease than female breast cancer?

Malani AK.

South Med J. 2007 Feb;100(2):197. Review. No abstract available.

PMID:
17330691
Items per page

Supplemental Content

Write to the Help Desk